Listen to me

I have a rare disease.

At Compass, we believe in empowering patients, especially those with rare diseases. We know that when patients understand their diagnosis, disease state, and medications, they are more likely to participate in their own care. When all stakeholders — caregivers, nurses, physicians, and healthcare workers — understand the patient experience, they can provide greater support, which can lead to better outcomes. Our services include Patient Positioning, Interactive Marketing, Patient Programs, Social Media, Research and Strategy.

Case Studies & White Papers:

Looking for success stories? We have a few to share.


Case Study

	Uniting a Community through Social Media PKU.com: Forging connections between phenylketonuria patients. Read more

White Paper

	Community Engagement in Rare Disease Patient Communities Building strong relationships with patients in the rare disease and orphan drug space is essential to a brand's success. Read more

Our Brands:

Compass is dedicated to improving the lives of patients suffering from rare diseases.

Innovation Lab:

Compass sponsors an ongoing series of industry-only events that enable participants to share best practices for commercializing orphan drugs.

In the rare disease space there are few competing brands, which creates a unique opportunity to share best practices. We all face the same challenges — how to determine optimum price, how to assess market size, how to best engage the patient community — and there is great benefit to sharing our collective experiences and knowledge. This is the idea behind our industry-only Innovation Lab events.

Innovation Lab events are by invitation only. If you are interested in attending our next Innovation Lab event, please register now!

From Our Blog:

Opinions and expertise from our dedicated employees.

Edimer To Develop Innovative Disease Awareness Campaign In Support Of EDI200 Clinical Trial Recruitment

By: Peter Nalen in Press Releases

-Compass Healthcare Marketers to Create a Community Outreach Program to Increase Awareness of XLHED, a Rare Genetic Disorder- PRINCETON, N.J., September 6, 2012 — Edimer Pharmaceuticals, a biotechnology co... Read more

Update from the 7th Annual Rare Disease and Orphan Drug Leadership Congress – Philadelphia, PA | July 2012

By: Julia Olff in Customer Targeting, Strategy

The theme for this year’s Congress was “Improve the Clinical Development Process. Accelerate Approval. Ensure Patient Access.” The Compass team led a panel presentation called “Defining &lsqu... Read more